© Globe Newswire
01.10.2025
ORY
LISTED
BME
ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors
News Preview
MADRID and CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and European leader in epigenetics, today announced that the European Patent Office (EPO) has issued a Decision to Grant for its patent application EP20712594.9, entitled “Combinations of...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
AMRX
LISTED
NASDAQ
Amneal to Report Third Quarter 2025 Results on October 30, 2025
News Preview
BRIDGEWATER, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its third quarter 2025 financial results on Thursday, October 30, 2025, prior to market open. The Company will host an audio webcast at 8:3...
Themefolio
Profiler
Peergroup
© ActuNews
30.09.2025
OXUR
LISTED
EURONEXT
Oxurion Publishes First Half 2025 Results
News Preview
Leuven, BELGIUM – September 30, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, published today its financial and business update for the six-month period ending June 30, 2025.
The half-year report is available in the ‘Investors' section of the Company's webs...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ActuNews
30.09.2025
OXUR
LISTED
EURONEXT
Oxurion publie ses résultats du premier semestre 2025
News Preview
Louvain, BELGIQUE – 30 Septembre, 2025 – 18:00 CET - Oxurion NV (Euronext Brussels: OXUR), entreprise biopharmaceutique basée à Louvain, a publié aujourd'hui ses résultats financiers et opérationnels pour le semestre clos le 30 Juin 2025.
Le rapport semestriel est disponible dans la section ‘...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ActuNews
30.09.2025
OXUR
LISTED
EURONEXT
Oxurion maakt halfjaarresultaten 2025 bekend
News Preview
Leuven, BELGIË – 30 September 2025 – 18:00 CET Oxurion NV (Euronext Brussel: OXUR) (de Vennootschap), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, maakt vandaag haar financiële en zakelijke update bekend voor het half jaar dat eindigde op 30 juni 2025.
Het halfjaarverslag is beschikbaar in de rubriek ‘Investe...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
OSE
LISTED
EURONEXT
Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman of the Board of Directors
News Preview
Full renewal of the Board of DirectorsElection of Dr. Markus Cappel as Chairman of the Board of Directors...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
EAPI
LISTED
EURONEXT
Change in Board’s Composition
News Preview
Paris – September 30, 2025 - EUROAPI today announces that, in line with best governance’s practices, and following his appointment as Recipharm’s Chief Financial Officer, effective October 1st, 2025, Rodolfo J. Savitzky will step down from his role as EUROAPI’s Independent Director and Chair of the Audit Committee, effective December 31, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ZEAL
LISTED
CPH
Total number of shares and voting rights in Zealand Pharma as of September 30, 2025
News Preview
Company announcement – No. 21 / 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
COLO B
LISTED
CPH
Coloplast A/S - Financial Calendar 2025-26
News Preview
Please see enclosed pdf....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ORNBV
LISTED
HEL
Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal
News Preview
ORION CORPORATION PRESS RELEASE 30 SEPTEMBER 2025 at 13.00 EEST ...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
SOBI
LISTED
STO
New number of shares and votes in Sobi
News Preview
STOCKHOLM, Sept. 30, 2025 /PRNewswire/ -- As per 30 September 2025, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 357,412,837 shares. All shares are common shares. The total number of votes is 357,412,837. The increase in the number of common shares and votes, and the decreas...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
SOBI
LISTED
STO
New number of shares and votes in Sobi
News Preview
STOCKHOLM, Sept. 30, 2025 /PRNewswire/ -- As per 30 September 2025, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 357,412,837 shares. All shares are common shares. The total number of votes is 357,412,837. The increase in the number of common shares and votes, and the decreas...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
30.09.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS30 September 2025 at 9.00 EEST ...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ERF
LISTED
EURONEXT
Microplastics in the Air: Global Study Uncovers Concerning Levels of Daily Exposure
News Preview
The PlasticDustCloud project, a global study led by the Eurofins Environment Testing network, has revealed alarming microplastic pollution in air, with deposition rates of up to 1,300 microplastics per square metre per day (/m2/day). Working with samples collected across 12 sites in 9 countries on 3 continents, this global study highlights the per...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
BAYN
LISTED
XETR
Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
News Preview
The Consumer Health division of Bayer has selected Interpublic Group (NYSE: IPG) as the global agency partner for all creative, production and media, responsible for marketing activities for some of the most trusted and well-known brands in self-care.
The selection of an integrated agency across brands and regions represents a new era in how Bay...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ANAB
LISTED
NASDAQ
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
News Preview
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it will host a virtual investor event on ANB033, its CD122 antagonist, at 4:30pm ET / 1:30pm PT on Tuesday, Oct. 14....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ANAB
LISTED
NASDAQ
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
News Preview
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, announced today that its Board of Directors approved plans to explore separating its business into two independent, publicly traded companies, each poised for strong, susta...
Themefolio
Profiler
Peergroup
© ActuNews
29.09.2025
ALTHX
LISTED
EURONEXT
Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercialization of Its Medicines for Rare Diseases
News Preview
With TX01 and Batten-1, THX Pharma is entering a new strategic phase focused on regulatory approval, early access, and international commercialization of its medicines.
Lyon, France – September 29, 2025, 6.30 pm CEST – THX Pharma (formerly Theranexus), a pharmaceutical company specializing in rare neurological diseases, today unveils it...
Themefolio
Profiler
Peergroup
© ActuNews
29.09.2025
ALTHX
LISTED
EURONEXT
Theranexus devient THX Pharma : une évolution stratégique vers la commercialisation de ses médicaments dans les maladies rares
News Preview
Avec TX01 et Batten-1, THX Pharma ouvre une nouvelle phase stratégique tournée vers l'enregistrement, l'accès précoce et la commercialisation internationale de ses médicaments.
Lyon, France – 29 septembre 2025, 6.30 pm CEST – THX Pharma (Theranexus), société pharmaceutique sp&eacu...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
FAGR
LISTED
EURONEXT
Fagron increases share capital through exercise subscription rights
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 29 September 2025 – 7PM CET...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
BAVA
LISTED
CPH
Consortium consisting of Nordic Capital and Permira extends offer period until 14 October 2025 and provides update on regulatory approvals in respect of the takeover offer to the shareholders of Bavarian Nordic
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
POAI
LISTED
NASDAQ
Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens
News Preview
Shawn Matthews, CEO of DNA Holdings and Former CEO of Cantor Fitzgerald, will join the Board of Directors upon the closing of the private placements...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.09.2025
SOON
LISTED
SIX
Sonova gewinnt Schweizer Innovations-Ranking
News Preview
Sonova Holding AG
/ Schlagwort(e): Sonstiges
Sonova gewinnt Schweizer Innovations-Ranking
29.09.2025 / 07:00 CET/CEST
Group Media & Investor Release
Stäfa (Schweiz), 29. September 2025 – Zum zweiten Mal in Folge ist Sonova als Nummer 1 unter den SMI-Unternehmen* im jährlichen Innovationsranking geführt, das von den ......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.09.2025
SOON
LISTED
SIX
Sonova wins Swiss innovation ranking
News Preview
Sonova Holding AG
/ Key word(s): Miscellaneous
Sonova wins Swiss innovation ranking
29.09.2025 / 07:00 CET/CEST
Group Media & Investor Release
Stäfa (Switzerland), September 29, 2025 – For the second consecutive year, Sonova is number one among SMI companies* in the annual innovation ranking compiled by business mag......
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
GMAB
LISTED
CPH
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
CLBX
LISTED
AIMX
Angle PLC Announces Presentation of Data on Glioblastoma
News Preview
CLINICAL study SHOWS DETECTION OF CTCs in glioblastoma PatientsGBM CTC isolation only possible with Parsortix label-free methodologyData presented at the 7th ACTC meeting GUILDFORD, SURREY / ACCESS Newswire / September 29, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) so...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS26 September 2025 at 16.30 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
AMRX
LISTED
NASDAQ
Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)
News Preview
Potential first-wave entry into the $4+ billion U.S. market and an important new growth driver for Amneal Potential first-wave entry into the $4+ billion U.S. market and an important new growth driver for Amneal...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
RAY B
LISTED
STO
RaySearch Brings Next-Level Innovation to ASTRO 2025
News Preview
STOCKHOLM, Sept. 26, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce its participation at ASTRO in San Francisco, California, September 28-30, where state of the art innovations will be presented under the global campaign Coding Energy to End Cancer. Attendees can watch demonstrations of the treatment planning system Ra...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
News Preview
OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
GMAB
LISTED
CPH
Grant of Restricted Stock Units and Warrants to Employees in Genmab
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© ActuNews
25.09.2025
ALTHX
LISTED
EURONEXT
THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
News Preview
THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
Lyon, France – 25 September 2025 – 6pm CEST – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, today publishes its first half results as of 30 June 2025.
Mathieu Charvériat, Chairman and CEO of Theranexus, comments: &ldq...
Themefolio
Profiler
Peergroup
© ActuNews
25.09.2025
ALTHX
LISTED
EURONEXT
THERANEXUS ANNONCE SES RÉSULTATS FINANCIERS DU PREMIER SEMESTRE 2025
News Preview
Lyon, France – 25 septembre 2025 – 18h CEST – Theranexus, société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, publie aujourd'hui ses résultats semestriels au 30 juin 2025.
Mathieu Charvériat, Président directeur général de Theranexus, d&eacut...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
NUTX
LISTED
NASDAQ
Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NUTX
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of NUTX during the cla...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025
News Preview
OSE Immunotherapeutics Reports its Cash Position as of June 30, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
BAYN
LISTED
XETR
Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada
News Preview
Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT® XL® 30 mg tablets1 in Canada. This strategic collaboration took effect on September 3, 2025.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250925537941/en/From Left to...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
BAYN
LISTED
XETR
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
News Preview
Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)’s Annual Scientific Meeting in Minneapolis, Minnesota, September 26-29, 2025.
In July 2025, the U.S. Food and Drug Administration (FDA) approved a new indication for KERENDIA...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
POAI
LISTED
NASDAQ
Predictive Oncology Announces 1-for-15 Reverse Stock Split
News Preview
Common Stock Will Begin Trading on Split-Adjusted Basis on September 30, 2025 Common Stock Will Begin Trading on Split-Adjusted Basis on September 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
FAGR
LISTED
EURONEXT
Fagron announces the acquisition of UCP in North America and FDA inspection update
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 25 September 2025 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
HNSA
LISTED
STO
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
News Preview
At 12 months, mean eGFR was 51.5 mL/min/1.73m2 in the imlifidase arm versus 19.3 mL/min/1.73m2 in the control arm with a statistically significant and clinically meaningful difference of 32.2 mL/min/1.73m2 ( p<0.0001)Imlifidase was generally well tolerated with a safety profile consistent with previous clinical trial experience Submission of a...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
HNSA
LISTED
STO
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
News Preview
At 12 months, mean eGFR was 51.5 mL/min/1.73m2 in the imlifidase arm versus 19.3 mL/min/1.73m2 in the control arm with a statistically significant and clinically meaningful difference of 32.2 mL/min/1.73m2 ( p<0.0001)Imlifidase was generally well tolerated with a safety profile consistent with previous clinical trial experience Submission of a...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
ZEAL
LISTED
CPH
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
News Preview
Press release – No. 14 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ICLR
LISTED
NASDAQ
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that it will release its financial results for the third quarter 2025 after the market closes on Wednesday, October 22, 2025. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, October 23, 2025 at...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© EQS Newswire
24.09.2025
GXI
LISTED
XETR
Gerresheimer comments on the audit by German BaFin
News Preview
Gerresheimer comments on the audit by German BaFin
Duesseldorf, 24. September 2025. Gerresheimer AG (ISIN: DE000A0LD6E6) has been informed by the German Federal Financial Supervisory Authority (BaFin) that it is initiating an ad hoc financial report audit.
According to BaFin, the audit concerns the recognition of profits from contracts with custo......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.09.2025
GXI
LISTED
XETR
Gerresheimer nimmt Stellung zur Prüfung durch die BaFin
News Preview
Gerresheimer nimmt Stellung zur Prüfung durch die BaFin
Düsseldorf, 24. September 2025. Die Gerresheimer AG (ISIN: DE000A0LD6E6), wurde von der Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) über die Einleitung einer anlassbezogenen Bilanzkontrollprüfung informiert.
Die Prüfung betrifft nach Angaben der BaFin die Gewinnrealisierung aus......
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
OSE
LISTED
EURONEXT
Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital
News Preview
Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share CapitalClarification in Response to Unfounded Accusations...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
MURA
LISTED
NASDAQ
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
News Preview
WALTHAM, Mass. and DUBLIN, Ireland, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) (“Mural”), a clinical-stage immuno-oncology company, today announces for the purposes of the Irish Takeover Panel Act, 1997, Takeover Rules 2022 (the “Irish Takeover Rules”), that it has published the definitive proxy statement of Mural relat...
Themefolio
Profiler
Peergroup
© BusinessWire
23.09.2025
HELP
LISTED
NASDAQ
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (”Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today highlights significant clinical and regulatory milestones and upcoming value-driving cata...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court
News Preview
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court...
Themefolio
Profiler
Peergroup
© BusinessWire
23.09.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
GMAB
LISTED
CPH
Major Shareholder Announcement
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
ATAI
LISTED
NASDAQ
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
News Preview
NEW YORK and AMSTERDAM and OXFORD, United Kingdom, Sept. 23, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, and Beckley Psytech Limited (“Beckley Psytech”), a private clinical-stage biop...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
DFTX
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grants
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 182,800 commo...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
NUTX
LISTED
NASDAQ
Kirby McInerney LLP Reminds Nutex Health Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm
News Preview
Kirby McInerney LLP reminds investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ:NUTX) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
If you s...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
GNFT
LISTED
EURONEXT
GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update
News Preview
Lille (France), Cambridge (Massachusetts, United States), (Zurich, Switzerland); September 22, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its first half 2025 financial results and provided a corporate up...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
IBAB
LISTED
EURONEXT
IBA – Transparency Notification
News Preview
...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
TEM
LISTED
NASDAQ
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its RNA-based Tempus xR IVD device. xR IVD will be offered as a life sciences tool to support drug development programs....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
CELC
LISTED
NASDAQ
Celcuity to Present Results from the Pivotal Phase 3 VIKTORIA-1 Trial at the 2025 European Society for Medical Oncology (ESMO) Congress
News Preview
MINNEAPOLIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that a late breaking abstract reporting clinical data from the Phase 3 VIKTORIA-1 trial has been selected for an oral presentation at the upcoming European So...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
